ArticleBMC medical imaging2025
An interpretable machine learning model based on CT imaging for predicting lymphovascular invasion and survival in bladder urothelial carcinoma: a multicenter study.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundLymphovascular invasion (LVI) is a critical prognostic factor in bladder cancer, affecting recurrence, survival, and overall prognosis. Traditional methods for diagnosing LVI, such as immunohistochemical staining, are costly and time-consuming, making non-invasive alternatives like radiomics-based models valuable. This study aimed to construct an interpretable machine learning model to predict LVI status and survival outcomes in patients with bladder urothelial carcinoma using preoperative CT images.
methodsThis study retrospectively enrolled patients with urothelial carcinoma who underwent radical cystectomy and preoperative contrast-enhanced CT from three medicine centers. Tumor regions were manually segmented, and radiomics features were extracted and selected through reproducibility testing, correlation analysis, and LASSO. Based on the selected radiomics features, machine learning classifiers, including SVM, were trained using five-fold cross-validation. A combined model was then constructed by integrating the radiomics signature with clinical risk factors. Model performance was evaluated by AUC, ACC, sensitivity, specificity, and survival analysis.
resultsThe SVM model showed high performance, with an AUC of 0.944 in the training set and 0.872 in the testing set. The combined model integrating clinical factor performed better, achieving an AUC of 0.952 in the training set and 0.901 in the testing set. The model's interpretability was enhanced using SHAP analysis, identifying key radiomics features associated with LVI, such as tumor shape and texture. Survival analysis indicated that patients predicted to be LVI-negative had significantly better disease-free survival compared to patients predicted to be LVI-positive.
conclusionsThis multicenter study demonstrates that the interpretable machine learning model based on preoperative CT images can effectively predict LVI status and survival outcomes in bladder urothelial carcinoma.
trial registrationThis study was retrospectively registered by Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. K2024-187-01) on April 12, 2024, and informed consent was waived.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.